The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Ion Channel Modulators Market Research Report 2024

Global Ion Channel Modulators Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1428708

No of Pages : 99

Ask Your Query

Synopsis

According to QYResearch’s new survey, global Ion Channel Modulators market is projected to reach US$ 14100 million in 2029, increasing from US$ 11510 million in 2022, with the CAGR of 2.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ion Channel Modulators market research.

Key companies engaged in the Ion Channel Modulators industry include Pfizer, Inc.(US), Neusentis, Inc.(US), AstraZeneca(UK), Aurora Biomed, Inc.(Canada), CalciMedica, Inc.(US), Cellectricon AB(Sweden), Convergence Pharmaceuticals Limited(UK), Cytocentrics AG(Germany) and Evotec AG(Germany), etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Ion Channel Modulators were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ion Channel Modulators market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ion Channel Modulators market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Pfizer, Inc.(US)
  •     Neusentis, Inc.(US)
  •     AstraZeneca(UK)
  •     Aurora Biomed, Inc.(Canada)
  •     CalciMedica, Inc.(US)
  •     Cellectricon AB(Sweden)
  •     Convergence Pharmaceuticals Limited(UK)
  •     Cytocentrics AG(Germany)
  •     Evotec AG(Germany)
  •     flyion GmbH(Germany)
  •     GlaxoSmithKline Plc.(UK)
  •     Nanion Technologies GmbH(Germany)
  •     NeuroSearch A/S(Denmark)
  •     Novartis AG(Switzerland)
  •     Parion Sciences, Inc.(US)
  •     Sanofi(France)
  •     Targacept, Inc.(US)
  •     Xention Limited(UK)
  •     Zalicus, Inc.(US)

Segment by Type

  •     Channel Blockers
  •     Channel Openers

Segment by Application

  •     Clinical Trials
  •     Hospital
  •     Other

By Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Ion Channel Modulators report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

 

 1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ion Channel Modulators Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Channel Blockers
        1.2.3 Channel Openers
    1.3 Market by Application
        1.3.1 Global Ion Channel Modulators Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Clinical Trials
        1.3.3 Hospital
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Ion Channel Modulators Market Perspective (2018-2029)
    2.2 Ion Channel Modulators Growth Trends by Region
        2.2.1 Global Ion Channel Modulators Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Ion Channel Modulators Historic Market Size by Region (2018-2023)
        2.2.3 Ion Channel Modulators Forecasted Market Size by Region (2024-2029)
    2.3 Ion Channel Modulators Market Dynamics
        2.3.1 Ion Channel Modulators Industry Trends
        2.3.2 Ion Channel Modulators Market Drivers
        2.3.3 Ion Channel Modulators Market Challenges
        2.3.4 Ion Channel Modulators Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Ion Channel Modulators Players by Revenue
        3.1.1 Global Top Ion Channel Modulators Players by Revenue (2018-2023)
        3.1.2 Global Ion Channel Modulators Revenue Market Share by Players (2018-2023)
    3.2 Global Ion Channel Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ion Channel Modulators Revenue
    3.4 Global Ion Channel Modulators Market Concentration Ratio
        3.4.1 Global Ion Channel Modulators Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ion Channel Modulators Revenue in 2022
    3.5 Ion Channel Modulators Key Players Head office and Area Served
    3.6 Key Players Ion Channel Modulators Product Solution and Service
    3.7 Date of Enter into Ion Channel Modulators Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Ion Channel Modulators Breakdown Data by Type
    4.1 Global Ion Channel Modulators Historic Market Size by Type (2018-2023)
    4.2 Global Ion Channel Modulators Forecasted Market Size by Type (2024-2029)

 5 Ion Channel Modulators Breakdown Data by Application
    5.1 Global Ion Channel Modulators Historic Market Size by Application (2018-2023)
    5.2 Global Ion Channel Modulators Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Ion Channel Modulators Market Size (2018-2029)
    6.2 North America Ion Channel Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Ion Channel Modulators Market Size by Country (2018-2023)
    6.4 North America Ion Channel Modulators Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Ion Channel Modulators Market Size (2018-2029)
    7.2 Europe Ion Channel Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Ion Channel Modulators Market Size by Country (2018-2023)
    7.4 Europe Ion Channel Modulators Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Ion Channel Modulators Market Size (2018-2029)
    8.2 Asia-Pacific Ion Channel Modulators Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Ion Channel Modulators Market Size by Region (2018-2023)
    8.4 Asia-Pacific Ion Channel Modulators Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Ion Channel Modulators Market Size (2018-2029)
    9.2 Latin America Ion Channel Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Ion Channel Modulators Market Size by Country (2018-2023)
    9.4 Latin America Ion Channel Modulators Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Ion Channel Modulators Market Size (2018-2029)
    10.2 Middle East & Africa Ion Channel Modulators Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Ion Channel Modulators Market Size by Country (2018-2023)
    10.4 Middle East & Africa Ion Channel Modulators Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Pfizer, Inc.(US)
        11.1.1 Pfizer, Inc.(US) Company Detail
        11.1.2 Pfizer, Inc.(US) Business Overview
        11.1.3 Pfizer, Inc.(US) Ion Channel Modulators Introduction
        11.1.4 Pfizer, Inc.(US) Revenue in Ion Channel Modulators Business (2018-2023)
        11.1.5 Pfizer, Inc.(US) Recent Development
    11.2 Neusentis, Inc.(US)
        11.2.1 Neusentis, Inc.(US) Company Detail
        11.2.2 Neusentis, Inc.(US) Business Overview
        11.2.3 Neusentis, Inc.(US) Ion Channel Modulators Introduction
        11.2.4 Neusentis, Inc.(US) Revenue in Ion Channel Modulators Business (2018-2023)
        11.2.5 Neusentis, Inc.(US) Recent Development
    11.3 AstraZeneca(UK)
        11.3.1 AstraZeneca(UK) Company Detail
        11.3.2 AstraZeneca(UK) Business Overview
        11.3.3 AstraZeneca(UK) Ion Channel Modulators Introduction
        11.3.4 AstraZeneca(UK) Revenue in Ion Channel Modulators Business (2018-2023)
        11.3.5 AstraZeneca(UK) Recent Development
    11.4 Aurora Biomed, Inc.(Canada)
        11.4.1 Aurora Biomed, Inc.(Canada) Company Detail
        11.4.2 Aurora Biomed, Inc.(Canada) Business Overview
        11.4.3 Aurora Biomed, Inc.(Canada) Ion Channel Modulators Introduction
        11.4.4 Aurora Biomed, Inc.(Canada) Revenue in Ion Channel Modulators Business (2018-2023)
        11.4.5 Aurora Biomed, Inc.(Canada) Recent Development
    11.5 CalciMedica, Inc.(US)
        11.5.1 CalciMedica, Inc.(US) Company Detail
        11.5.2 CalciMedica, Inc.(US) Business Overview
        11.5.3 CalciMedica, Inc.(US) Ion Channel Modulators Introduction
        11.5.4 CalciMedica, Inc.(US) Revenue in Ion Channel Modulators Business (2018-2023)
        11.5.5 CalciMedica, Inc.(US) Recent Development
    11.6 Cellectricon AB(Sweden)
        11.6.1 Cellectricon AB(Sweden) Company Detail
        11.6.2 Cellectricon AB(Sweden) Business Overview
        11.6.3 Cellectricon AB(Sweden) Ion Channel Modulators Introduction
        11.6.4 Cellectricon AB(Sweden) Revenue in Ion Channel Modulators Business (2018-2023)
        11.6.5 Cellectricon AB(Sweden) Recent Development
    11.7 Convergence Pharmaceuticals Limited(UK)
        11.7.1 Convergence Pharmaceuticals Limited(UK) Company Detail
        11.7.2 Convergence Pharmaceuticals Limited(UK) Business Overview
        11.7.3 Convergence Pharmaceuticals Limited(UK) Ion Channel Modulators Introduction
        11.7.4 Convergence Pharmaceuticals Limited(UK) Revenue in Ion Channel Modulators Business (2018-2023)
        11.7.5 Convergence Pharmaceuticals Limited(UK) Recent Development
    11.8 Cytocentrics AG(Germany)
        11.8.1 Cytocentrics AG(Germany) Company Detail
        11.8.2 Cytocentrics AG(Germany) Business Overview
        11.8.3 Cytocentrics AG(Germany) Ion Channel Modulators Introduction
        11.8.4 Cytocentrics AG(Germany) Revenue in Ion Channel Modulators Business (2018-2023)
        11.8.5 Cytocentrics AG(Germany) Recent Development
    11.9 Evotec AG(Germany)
        11.9.1 Evotec AG(Germany) Company Detail
        11.9.2 Evotec AG(Germany) Business Overview
        11.9.3 Evotec AG(Germany) Ion Channel Modulators Introduction
        11.9.4 Evotec AG(Germany) Revenue in Ion Channel Modulators Business (2018-2023)
        11.9.5 Evotec AG(Germany) Recent Development
    11.10 flyion GmbH(Germany)
        11.10.1 flyion GmbH(Germany) Company Detail
        11.10.2 flyion GmbH(Germany) Business Overview
        11.10.3 flyion GmbH(Germany) Ion Channel Modulators Introduction
        11.10.4 flyion GmbH(Germany) Revenue in Ion Channel Modulators Business (2018-2023)
        11.10.5 flyion GmbH(Germany) Recent Development
    11.11 GlaxoSmithKline Plc.(UK)
        11.11.1 GlaxoSmithKline Plc.(UK) Company Detail
        11.11.2 GlaxoSmithKline Plc.(UK) Business Overview
        11.11.3 GlaxoSmithKline Plc.(UK) Ion Channel Modulators Introduction
        11.11.4 GlaxoSmithKline Plc.(UK) Revenue in Ion Channel Modulators Business (2018-2023)
        11.11.5 GlaxoSmithKline Plc.(UK) Recent Development
    11.12 Nanion Technologies GmbH(Germany)
        11.12.1 Nanion Technologies GmbH(Germany) Company Detail
        11.12.2 Nanion Technologies GmbH(Germany) Business Overview
        11.12.3 Nanion Technologies GmbH(Germany) Ion Channel Modulators Introduction
        11.12.4 Nanion Technologies GmbH(Germany) Revenue in Ion Channel Modulators Business (2018-2023)
        11.12.5 Nanion Technologies GmbH(Germany) Recent Development
    11.13 NeuroSearch A/S(Denmark)
        11.13.1 NeuroSearch A/S(Denmark) Company Detail
        11.13.2 NeuroSearch A/S(Denmark) Business Overview
        11.13.3 NeuroSearch A/S(Denmark) Ion Channel Modulators Introduction
        11.13.4 NeuroSearch A/S(Denmark) Revenue in Ion Channel Modulators Business (2018-2023)
        11.13.5 NeuroSearch A/S(Denmark) Recent Development
    11.14 Novartis AG(Switzerland)
        11.14.1 Novartis AG(Switzerland) Company Detail
        11.14.2 Novartis AG(Switzerland) Business Overview
        11.14.3 Novartis AG(Switzerland) Ion Channel Modulators Introduction
        11.14.4 Novartis AG(Switzerland) Revenue in Ion Channel Modulators Business (2018-2023)
        11.14.5 Novartis AG(Switzerland) Recent Development
    11.15 Parion Sciences, Inc.(US)
        11.15.1 Parion Sciences, Inc.(US) Company Detail
        11.15.2 Parion Sciences, Inc.(US) Business Overview
        11.15.3 Parion Sciences, Inc.(US) Ion Channel Modulators Introduction
        11.15.4 Parion Sciences, Inc.(US) Revenue in Ion Channel Modulators Business (2018-2023)
        11.15.5 Parion Sciences, Inc.(US) Recent Development
    11.16 Sanofi(France)
        11.16.1 Sanofi(France) Company Detail
        11.16.2 Sanofi(France) Business Overview
        11.16.3 Sanofi(France) Ion Channel Modulators Introduction
        11.16.4 Sanofi(France) Revenue in Ion Channel Modulators Business (2018-2023)
        11.16.5 Sanofi(France) Recent Development
    11.17 Targacept, Inc.(US)
        11.17.1 Targacept, Inc.(US) Company Detail
        11.17.2 Targacept, Inc.(US) Business Overview
        11.17.3 Targacept, Inc.(US) Ion Channel Modulators Introduction
        11.17.4 Targacept, Inc.(US) Revenue in Ion Channel Modulators Business (2018-2023)
        11.17.5 Targacept, Inc.(US) Recent Development
    11.18 Xention Limited(UK)
        11.18.1 Xention Limited(UK) Company Detail
        11.18.2 Xention Limited(UK) Business Overview
        11.18.3 Xention Limited(UK) Ion Channel Modulators Introduction
        11.18.4 Xention Limited(UK) Revenue in Ion Channel Modulators Business (2018-2023)
        11.18.5 Xention Limited(UK) Recent Development
    11.19 Zalicus, Inc.(US)
        11.19.1 Zalicus, Inc.(US) Company Detail
        11.19.2 Zalicus, Inc.(US) Business Overview
        11.19.3 Zalicus, Inc.(US) Ion Channel Modulators Introduction
        11.19.4 Zalicus, Inc.(US) Revenue in Ion Channel Modulators Business (2018-2023)
        11.19.5 Zalicus, Inc.(US) Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock